SAREUM HOLDINGS PLC ORD 0.025P chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share N/A
Dividend & YieldN/A£ (N/A)
Beta -0.24
Market capitalization 98.7M
Operating cash flow -2.13M
ESG Scores unknown

Company description

Sareum Holdings plc, a specialist drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2/JAK1 kinase. It has collaborations with Hebei Medical University Biomedical Engineering Center and Sierra Oncology, Inc. The company was founded in 2003 and is based in Cambridge, the United Kingdom.

Sector: Healthcare - Industry: Biotechnology

Financial data

Financial Statements

Cashflow Statement 2019-06-30 2020-06-30 2021-06-30 2022-06-30
Change To Liabilities -36.53k 51.61k 85.62k
Total Cashflows From Investing Activities 4.08k 1.29k -37.86k -2k
Net Borrowings
Total Cash From Financing Activities 803.21k 1.7M 2.49M 3.71M
Change To Operating Activities 227k 227k 227k 227k
Issuance Of Stock 799k 1.7M 2.49M 3.71M
Net Income -1.45M -985.91k -1.5M -2.17M
Change In Cash -455.93k 883.51k 883.3k 1.57M
Effect Of Exchange Rate
Total Cash From Operating Activities -1.26M -813.09k -1.57M -2.13M
Depreciation 8k 635 1.09k 2k
Change To Account Receivables 74.14k -292 -87.55k
Other Cashflows From Financing Activities 4.21k
Change To Netincome 143.62k 120.87k -69.43k -188k
Capital Expenditures -3.26k -3.26k -3k -3k

Income Statement 2019-06-30 2020-06-30 2021-06-30 2022-06-30
Research Development
Income Before Tax -1.68M -1.12M -1.72M -2.58M
Net Income -1.45M -985.91k -1.5M -2.17M
Selling General Administrative 1.68M 1.14M 1.88M 2.58M
Gross Profit 47.2k
Ebit -1.68M -1.09M -1.7M -2.58M
Operating Income -1.68M -1.09M -1.7M -2.58M
Interest Expense
Income Tax Expense -229.91k -134.21k -217.5k -407k
Total Revenue 47.2k
Cost Of Revenue
Total Other Income ExpenseNet -5.93k -25.17k -13.86k -2k
Net Income From Continuing Ops -1.45M -985.91k -1.5M -2.17M
Net Income Applicable To Common Shares -1.45M -985.91k -1.5M -2.17M

Balance Sheet Statement 2019-06-30 2020-06-30 2021-06-30 2022-06-30
Total Liabilities 146.93k 198.54k 284.15k 455k
Total Stockholder Equity 1.09M 1.8M 2.8M 4.33M
Other Current Liabilities 14.33k 69.76k 156.28k 5k
Total Assets 1.24M 2M 3.08M 4.79M
Common Stock 719k 810.43k 833.22k 851k
Other Current Assets
Retained Earnings -13.19M -14.18M -15.64M -17.77M
Treasury Stock 407.9k 407.9k 361.85k 325k
Cash 919.34k 1.8M 2.69M 4.26M
Total Current Liabilities 146.93k 198.54k 284.15k 455k
Other Stockholder Equity 407.9k 407.9k 361.85k 325k
Property, Plant, and Equipment 2.63k 1.54k 2k
Total Current Assets 1.21M 2M 3.05M 4.76M
Net Tangible Assets 1.09M 1.8M 2.8M 4.33M
Net Receivables 243.99k 144.49k 321.4k 455k
Accounts Payable 83.56k 36.55k 99.84k 387k


Insider Transactions

Here are the insider transactions of stock shares related to SAREUM HOLDINGS PLC ORD 0.025P:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Parker (Stephen Barry)Bought at price 0.05 per share.D2021-11-23277.78k
Birch (Clive)D2021-11-10
Mitchell (Tim J.)Exercise of Option at price 0.01 per share.D2021-11-102.57M
Mitchell (Tim J.)Sold at price 0.08 per share.D2021-11-102.57M
Mitchell (Tim J.)D2021-11-10
Owen (Michael)D2021-11-10
Parker (Stephen Barry)D2021-11-10
Reader (John C)Exercise of Option at price 0.01 per share.D2021-11-102.57M
Reader (John C)D2021-11-10

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to SAREUM HOLDINGS PLC ORD 0.025P. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on SAREUM HOLDINGS PLC ORD 0.025P

Here is the result of two systematic investment strategies applied to SAREUM HOLDINGS PLC ORD 0.025P. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on SAREUM HOLDINGS PLC ORD 0.025P

The following chart shows the equity curve of the two systematic investment strategies applied to SAREUM HOLDINGS PLC ORD 0.025P:

SAREUM HOLDINGS PLC ORD 0.025P automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 672.65% on the backtest period.

Performance at glance

Performance

672.65 %

Latent gain

13462.66 £

Invested capital

2001.44 £

Annualized return

163.26 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on SAREUM HOLDINGS PLC ORD 0.025P

This is the result of two momentum investment strategies applied to SAREUM HOLDINGS PLC ORD 0.025P. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on SAREUM HOLDINGS PLC ORD 0.025P

The following chart shows all the entries opened by the momentum investment system on SAREUM HOLDINGS PLC ORD 0.025P:

SAREUM HOLDINGS PLC ORD 0.025P momentum entries
  • The first momentum investment strategy would give 852.28% of return on SAREUM HOLDINGS PLC ORD 0.025P. That represents 36209.98£ of latent gain with 4248.62£ of employed capital.
  • The second momentum investment strategy would give 933.86% of return on SAREUM HOLDINGS PLC ORD 0.025P. That represents 35010.93£ of latent gain with 3749.07£ of employed capital.
Performance at glance (1Q Momentum)

Performance

852.28 %

Latent gain

36209.98 £

Invested capital

4248.62 £

Annualized return

129.14 %
Performance at glance (2Q Momentum)

Performance

933.86 %

Latent gain

35010.93 £

Invested capital

3749.07 £

Annualized return

256.55 %

Momentum equity curve on SAREUM HOLDINGS PLC ORD 0.025P

The following chart shows the equity curve of the two momentum strategies applied to SAREUM HOLDINGS PLC ORD 0.025P:

SAREUM HOLDINGS PLC ORD 0.025P momentum equity

Note: the dividends potentially given by SAREUM HOLDINGS PLC ORD 0.025P are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on SAREUM HOLDINGS PLC ORD 0.025P

The following chart shows the employed capital evolution of the two momentum strategies on SAREUM HOLDINGS PLC ORD 0.025P since the beginning:

SAREUM HOLDINGS PLC ORD 0.025P

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250£, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000£.


Buy the dip strategy result on SAREUM HOLDINGS PLC ORD 0.025P

Buy the dip entry openings on SAREUM HOLDINGS PLC ORD 0.025P

SAREUM HOLDINGS PLC ORD 0.025P

The performance achieved by the robo-advisor on SAREUM HOLDINGS PLC ORD 0.025P is 273.77%. That represents 684.7$ of latent gain with 250.1£ of employed capital. The following chart shows SAREUM HOLDINGS PLC ORD 0.025P stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of SAREUM HOLDINGS PLC ORD 0.025P, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

273.77 %

Latent gain

684.7 £

Invested capital

250.1 £

Annualized return

129.14 %

Equity curve of the strategy applied to SAREUM HOLDINGS PLC ORD 0.025P

The following chart shows the result of the investment strategy applied to SAREUM HOLDINGS PLC ORD 0.025P:

SAREUM HOLDINGS PLC ORD 0.025P

Note: the dividends potentially given by SAREUM HOLDINGS PLC ORD 0.025P are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on SAREUM HOLDINGS PLC ORD 0.025P

The following chart shows the employed capital evolution since the beginning of the investment strategy on SAREUM HOLDINGS PLC ORD 0.025P:

SAREUM HOLDINGS PLC ORD 0.025P

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on SAREUM HOLDINGS PLC ORD 0.025P

In this section, I will compare the three previous investment strategies applied to SAREUM HOLDINGS PLC ORD 0.025P.

Equity curve comparison on SAREUM HOLDINGS PLC ORD 0.025P

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

SAREUM HOLDINGS PLC ORD 0.025P investment strategy comparison

Employed capital comparison on SAREUM HOLDINGS PLC ORD 0.025P

SAREUM HOLDINGS PLC ORD 0.025P investment comparison

Performance comparison on SAREUM HOLDINGS PLC ORD 0.025P

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 672.65% 13462.66£ 2001.44£ 163.26%
Momentum 1 quarter 852.28% 36209.98£ 4248.62£ 219.66%
Momentum 2 quarters 933.86% 35010.93£ 3749.07£ 256.55%
Non-directional 273.77% 684.7£ 250.1£ 129.14%
Annualized return comparison

Automatic investment

163.26 %

Momentum 1Q

256.55 %

Momentum 2Q

256.55 %

Non-directional

129.14 %

Correlated stocks

Here are the most positively and negatively correlated stocks with SAREUM HOLDINGS PLC ORD 0.025P:

Positive correlations

Most correlated stocks this year

  • SAREUM HOLDINGS PLC ORD 0.025P

  • Most correlated stocks last 3 months

  • SAREUM HOLDINGS PLC ORD 0.025P

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months

  • BAR PACIFIC
  • AIR LIQUIDE
  • AXWAY SOFTWARE
  • Karuna Therapeutics Inc

  • Note: The algorithm computes the probability of correlation between SAREUM HOLDINGS PLC ORD 0.025P and the other stocks. There may be false positives or some missing correlated stocks. If the price of SAREUM HOLDINGS PLC ORD 0.025P does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name SAREUM HOLDINGS PLC ORD 0.025P
    Country United Kingdom
    City Cambridge
    Address Langford Arch
    Phone 44 1223 497 700
    Website www.sareum.com
    FullTime employees
    Industry Biotechnology
    Sector Healthcare
    Exchange XLON
    Ticker SAR.XLON
    Market www.londonstockexchange.com

    SAREUM HOLDINGS PLC ORD 0.025P ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown